228 related articles for article (PubMed ID: 26252773)
1. The Overexpression of IQGAP1 and β-Catenin Is Associated with Tumor Progression in Hepatocellular Carcinoma In Vitro and In Vivo.
Jin X; Liu Y; Liu J; Lu W; Liang Z; Zhang D; Liu G; Zhu H; Xu N; Liang S
PLoS One; 2015; 10(8):e0133770. PubMed ID: 26252773
[TBL] [Abstract][Full Text] [Related]
2. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C
Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875
[TBL] [Abstract][Full Text] [Related]
3. Scaffolding Protein IQGAP1 Is Dispensable, but Its Overexpression Promotes Hepatocellular Carcinoma via YAP1 Signaling.
Delgado ER; Erickson HL; Tao J; Monga SP; Duncan AW; Anakk S
Mol Cell Biol; 2021 Mar; 41(4):. PubMed ID: 33526450
[TBL] [Abstract][Full Text] [Related]
4. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.
Feng H; Zhu M; Zhang R; Wang Q; Li W; Dong X; Chen Y; Lu Y; Liu K; Lin B; Guo J; Li M
J Cell Mol Med; 2019 Apr; 23(4):2536-2548. PubMed ID: 30672133
[TBL] [Abstract][Full Text] [Related]
5. Nek2 augments sorafenib resistance by regulating the ubiquitination and localization of β-catenin in hepatocellular carcinoma.
Deng L; Sun J; Chen X; Liu L; Wu D
J Exp Clin Cancer Res; 2019 Jul; 38(1):316. PubMed ID: 31319849
[TBL] [Abstract][Full Text] [Related]
6. IQGAP1 gene silencing induces apoptosis and decreases the invasive capacity of human hepatocellular carcinoma cells.
Zoheir KM; Abd-Rabou AA; Harisa GI; Kumar A; Ahmad SF; Ansari MA; Abd-Allah AR
Tumour Biol; 2016 Oct; 37(10):13927-13939. PubMed ID: 27488117
[TBL] [Abstract][Full Text] [Related]
7. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
Zhang N; Chen X
Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
[TBL] [Abstract][Full Text] [Related]
8. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA CASC2c inhibited cell proliferation in hepatocellular carcinoma by inactivated ERK1/2 and Wnt/β-catenin signaling pathway.
Li QY; Yang K; Liu FG; Sun XG; Chen L; Xiu H; Liu XS
Clin Transl Oncol; 2020 Mar; 22(3):302-310. PubMed ID: 31625123
[TBL] [Abstract][Full Text] [Related]
10. CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.
Fan X; Ma X; Cui L; Dang S; Qu J; Zhang J; Wang X; Mao Z
Oncotarget; 2016 Dec; 7(49):80404-80414. PubMed ID: 27829235
[TBL] [Abstract][Full Text] [Related]
11. TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.
Yang YF; Zhang MF; Tian QH; Zhang CZ
J Cell Sci; 2017 Sep; 130(18):3108-3115. PubMed ID: 28754688
[TBL] [Abstract][Full Text] [Related]
12. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling.
Gao H; Yin FF; Guan DX; Feng YX; Zheng QW; Wang X; Zhu M; Zhang XL; Cheng SQ; Chen TW; Jiang H; Zhang EB; Wang JJ; Ni QZ; Yuan YM; Zhang FK; Ma N; Cao HJ; Wang YK; Li JJ; Xie D
Cell Prolif; 2019 May; 52(3):e12583. PubMed ID: 30793395
[TBL] [Abstract][Full Text] [Related]
13. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.
Liu Y; Ye X; Zhang JB; Ouyang H; Shen Z; Wu Y; Wang W; Wu J; Tao S; Yang X; Qiao K; Zhang J; Liu J; Fu Q; Xie Y
Oncogene; 2015 Oct; 34(44):5524-35. PubMed ID: 25684142
[TBL] [Abstract][Full Text] [Related]
14. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
[TBL] [Abstract][Full Text] [Related]
15. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
16. TLR4 Influences Hepatitis B Virus Related Hepatocellular Carcinoma by Regulating the Wnt/β-Catenin Pathway.
Yin Y; Li F; Li S; Cai J; Shi J; Jiang Y
Cell Physiol Biochem; 2017; 42(2):469-479. PubMed ID: 28578348
[TBL] [Abstract][Full Text] [Related]
17. Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent.
Schmidt VA; Chiariello CS; Capilla E; Miller F; Bahou WF
Mol Cell Biol; 2008 Mar; 28(5):1489-502. PubMed ID: 18180285
[TBL] [Abstract][Full Text] [Related]
18. SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation.
Liu H; Hu J; Wei R; Zhou L; Pan H; Zhu H; Huang M; Luo J; Xu W
J Exp Clin Cancer Res; 2018 Sep; 37(1):229. PubMed ID: 30249289
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of RIP140 in hepatocellular carcinoma promoted the growth and migration of the cancer cells.
Zhang D; Wang Y; Dai Y; Wang J; Suo T; Pan H; Liu H; Shen S; Liu H
Tumour Biol; 2015 Mar; 36(3):2077-85. PubMed ID: 25391428
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.
Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY
Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
